Ascentage Pharma AAPG
$11.97 −$0.47 (-3.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.97 0.00%
Open$12.26
Prev close$12.44
Day range$11.97 – $12.26
Volume5,039
Market cap$1.12B
P/E (TTM)–
Dividend yield–
AAPG Stock News
Headlines matching Ascentage Pharma or the AAPG ticker, most recent first.
- B. Riley Securities Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45
- Oppenheimer Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45
- Analysts Offer Insights on NA Companies: Ascentage Pharma Group International Unsponsored ADR (AAPG), Fatpipe, Inc. (FATN) and Aptera Motors Corp. Class B (SEV)
- BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
- Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating
- Oppenheimer Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45
- B. Riley Securities Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45
- Piper Sandler Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
- Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $22.34 Negative
- Deutsche Bank Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $40
- J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $46 Negative
- Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $51
- BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48
- BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48
- J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $33 Negative
No comments yet — be the first to weigh in on AAPG.
Sign in to join the discussion.